Asia-Pacific
Swati Sharma and Revanta Mathur at Cyril Amarchand Mangaldas explain how they overcame IP office objections to secure victory for a tyre manufacturer
Amanda Griffiths, who will be tasked with expanding the firm’s trademark offering in New Zealand, says she hopes to offer greater flexibility to clients at her new home
Meryl Koh, equity director and litigator at Drew & Napier in Singapore, discusses an uptick in cross-border litigation and why collaboration across practice areas is becoming crucial
Qantm IP’s CEO and AI programme lead discuss the business’s investment and M&A plans, and reveal their tech ambitions
Sponsored
Sponsored
-
Sponsored by Tilleke & GibbinsKhin Yadanar Htay and Khin Myo Myo Aye of Tilleke & Gibbins summarise Myanmar’s new Geographical Indication Rules, covering application procedures, local representation requirements, and GI logo authorisation for domestic and international applicants -
Sponsored by Tilleke & GibbinsProactive measures are needed to counteract opportunistic bad-faith actors, say Diep Thi Bich Le and Hang Thi Thanh Phan of T&G Law Firm LLC (TGVN), the local associate of Tilleke & Gibbins
-
Sponsored by Hanol IP & LawMin Son of Hanol IP & Law explains how a ruling has rejected attempts to limit protection to initially approved drug indications
-
Sponsored by Saint Island International Patent & Law OfficesThe District Court of New Taipei City’s findings on copyright infringement through bulk reproduction highlight key lessons on fair use and data scraping, says Steven Liao of Saint Island International Patent & Law Offices
-
Sponsored by RNA, Technology and IP AttorneysThere are strategic intellectual property considerations at every stage of a brand’s development. Ranjan Narula, Aditi Roy Chowdhury, and Simran Singh of RNA, Technology and IP Attorneys outline how startups can take a phased approach
-
Sponsored by Wanhuida Intellectual PropertyXiaoping Wu of Wanhuida Intellectual Property explains how the CNIPA’s recent invalidation of a sustained-release patent illustrates key considerations in assessing inventive step for pharmaceutical formulation patents
